The global arteriovenous fistula (AVF) treatment market is projected to reach approximately USD 868.8 million in 2025 and ...

(Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced today that the results from its V007 ...

The ACCESS 2 Study was designed to validate the post-hoc results from ACCESS and further evaluate the effectiveness of Sirogen to improve outcomes in patients requiring an AV fistula.

The primary focus of this study will be to assess the pain control following surgery with the utilization of ambit electronic pump through visual analogue scale (VAS), numeric rating scale (NRS), ...

Evaluating the Effectiveness of Systemic Heparin During Arteriovenous Fistula Creation by Emulating a Target Trial Journal: American Journal of Epidemiology Published: 2024-06-03 DOI: 10.1093/aje ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

The market for arteriovenous fistula devices is anticipated to expand at a CAGR of 7.5% during the forecast period of 2023 and 2031, owing to a number of factors. In this exhaustive overview, we will ...

The vascular access types consist of the central venous catheter (CVC), arteriovenous graft (AVG), and autogenous arteriovenous fistula (AVF) (1). Compared with CVC or AVG, the incidence of ...

4 Department of Nephrology, Wuwei People’s Hospital, Wuwei, China Objective: Currently, percutaneous endovascular creation of arteriovenous fistula (AVF) shows excellent outcomes. However, few ...